SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-022264
Filing Date
2024-04-26
Accepted
2024-04-26 08:01:18
Documents
21
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20023217x1_def14a.htm   iXBRL DEF 14A 829662
6 sig_danielluckshire.jpg GRAPHIC 18634
7 ny20023217x1_pvp01.jpg GRAPHIC 133285
8 ny20023217x1_pvp02.jpg GRAPHIC 114520
9 sig_dnguyen.jpg GRAPHIC 15325
10 ny20023217x1_pc01.jpg GRAPHIC 623789
11 ny20023217x1_pc02.jpg GRAPHIC 452447
12 ny20023217x1_pvp03x1.jpg GRAPHIC 125792
  Complete submission text file 0001140361-24-022264.txt   5246830

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA siga-20240611.xsd EX-101.SCH 4576
3 INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE siga-20240611_def.xml EX-101.DEF 4613
4 INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE siga-20240611_lab.xml EX-101.LAB 7130
5 INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE siga-20240611_pre.xml EX-101.PRE 3596
24 EXTRACTED XBRL INSTANCE DOCUMENT ny20023217x1_def14a_htm.xml XML 147168
Mailing Address 31 EAST 62ND STREET NEW YORK NY 10065
Business Address 31 EAST 62ND STREET NEW YORK NY 10065 212-672-9100
SIGA TECHNOLOGIES INC (Filer) CIK: 0001010086 (see all company filings)

IRS No.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38436 | Film No.: 24878870
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)